Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.
A radiologist and public health expert breaks down what we know about President Trump’s CT scan, and what this means for his health.
Differences in vaccination policies illustrate the importance of context, regarding distinct healthcare systems and the vaccine stance taken by public health officials.
Childhood vaccine schedules among U.S. peers differ marginally. Unlike the U.S., however, peer health officials don’t sow doubt among the public about vaccination.
Medicare’s cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, patients can better afford their medications.
FDA approval for the first brain stimulation device cleared for home use in treating depression
In this week’s edition of The Prototype we look at the biggest tech breakthroughs of 2025–and the year’s best music.
It isn’t wrong to promote healthier living. But misinforming the public on the flu vaccine and downplaying the disease’s impact aren’t in public health’s interest.
At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but 54% of users report affordability challenges.
As healthcare AI matures in 2026, proof beats promises, trust outperforms technology, and humans reclaim the center of care.